Next-Generation Boron Neutron Capture Therapy (BNCT) for Cancer Treatment
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: 30 April 2026 | Viewed by 151
Special Issue Editors
Interests: particle detectors; radiation detection; dosimetry; medical physics; imaging
Interests: particle detectors; detector technologies for medical applications
Special Issue Information
Dear Colleagues,
Boron Neutron Capture Therapy (BNCT) has re-emerged as a promising modality in cancer treatment, offering unique biological selectivity through boron-loaded compounds and targeted neutron irradiation. Recent advances in boron agent development and precise dosimetry and the establishment of accelerator-based neutron sources have opened up new clinical and technological frontiers. In parallel, innovations in detector systems and imaging, as well as in computational modeling and treatment planning, have reinforced the role of BNCT in modern oncology. With clinical trials progressing worldwide and national centers becoming operational, there is a growing need to consolidate knowledge and share multidisciplinary advances in this dynamic field.
We are pleased to invite you to contribute to this Special Issue dedicated to showcasing next-generation BNCT strategies for cancer treatment.
This Special Issue will present a comprehensive overview of the current state and future directions of BNCT in both clinical and technological dimensions. It will particularly focus on recent progress in medical applications, including the development and assessment of boron carriers, the refinement of dosimetry and radiobiological modeling, innovations in neutron and gamma detection systems, novel imaging techniques, simulation-based treatment planning, and the construction and commissioning of BNCT facilities. This Special Issue is well aligned with the journal’s scope, including nuclear technologies and their application to medical physics and radiation therapy.
For this Special Issue, original research articles and comprehensive reviews are welcome. Research areas may include (but are not limited to) the following topics:
- Clinical studies and trials in BNCT;
- The development of novel boron-containing agents and drug delivery systems;
- Dosimetry strategies and radiation quality assessment;
- Detectors for in vivo and in vitro dose monitoring;
- Imaging techniques;
- Simulation tools and treatment planning systems;
- Radiobiological modeling and response evaluation;
- Technological innovations in BNCT facility design and commissioning;
- Quality assurance and safety protocols in BNCT;
- Multidisciplinary approaches combining BNCT with other modalities.
We look forward to receiving your contributions and advancing this important area together.
Dr. Dayron Ramos López
Dr. Gabriella Pugliese
Dr. Raffaella Radogna
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- BNCT
- boron agents
- dosimetry
- neutron detectors
- cancer therapy
- imaging
- simulation
- neutron sources
- treatment planning
- medical physics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
